parainfluenza hemagglutinin neuraminidase inhibitors (BioCryst)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameparainfluenza hemagglutinin neuraminidase inhibitors (BioCryst)
Drug Alias Nameparainfluenza therapy (BioCryst)BCX-2798BCX-2855
ClassificationSmall molecules
Mechanisms of ActionNeuraminidase inhibitorsInfluenza virus hemagglutinin glycoproteins inhibitors
TargetsNeuraminidaseInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsParamyxoviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocryst Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsParamyxoviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A